RRM2 and hepatocellular carcinoma: Lastly, for the group of upregulated genes in HCC, RRM2 has also been linked with low overall survival [11, 28], leading to exhaustive cancer research suggesting targeting its inhibition for different types of tumour treatments [47, 48, 50, 70].